Trastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. [electronic resource]
Producer: 20061218Description: 2660-1 p. digitalISSN:- 0959-8049
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Transitional Cell -- drug therapy
- Drug Administration Schedule
- Humans
- Middle Aged
- Neoplasm Proteins -- metabolism
- Receptor, ErbB-2 -- metabolism
- Trastuzumab
- Treatment Outcome
- Urinary Bladder Neoplasms -- drug therapy
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.